FULGENT GENETICS, INC. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
FULGENT GENETICS, INC. (FLGT) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of $21.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2019-03-22
- FULGENT GENETICS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2018-12-31 was $11.00K, a 10.00% increase year-over-year.
- FULGENT GENETICS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2018-09-30 was $15.00K, a 50.00% increase year-over-year.
- FULGENT GENETICS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2018-06-30 was $19.00K, a 171.43% increase year-over-year.
- FULGENT GENETICS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2018-03-31 was -$14.00K, a 300.00% decline year-over-year.
- FULGENT GENETICS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2018 was $21.00K, a 43.24% decline from fiscal 2017.
- FULGENT GENETICS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2017 was $37.00K, a 36.21% decline from fiscal 2016.
- FULGENT GENETICS, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2016 was $58.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $26.00K derived: sum of 2 quarters · filed 2019-03-22 | $45.00K derived: sum of 3 quarters · filed 2019-03-22 | $21.00K 10-K · filed 2019-03-22 | |
| 2018-09-30 | $15.00K 10-Q · filed 2018-11-09 | $34.00K derived: sum of 2 quarters · filed 2018-11-09 | $10.00K 10-Q · filed 2018-11-09 | $30.00K derived: sum of 4 quarters · filed 2019-03-22 | |
| 2018-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $5.00K 10-Q · filed 2018-08-13 | $15.00K derived: sum of 3 quarters · filed 2019-03-22 | $25.00K derived: sum of 4 quarters · filed 2019-03-22 | |
| 2018-03-31 | -$14.00K 10-Q · filed 2018-08-13 | $55.00K 10-Q · filed 2018-05-14 | -$4.00K derived: sum of 2 quarters · filed 2019-03-22 | $6.00K derived: sum of 3 quarters · filed 2019-03-22 | $13.00K derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $20.00K derived: sum of 2 quarters · filed 2019-03-22 | $27.00K derived: sum of 3 quarters · filed 2019-03-22 | $37.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $10.00K 10-Q · filed 2018-11-09 | $17.00K derived: sum of 2 quarters · filed 2018-11-09 | $27.00K 10-Q · filed 2018-11-09 | $82.00K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | $7.00K 10-Q · filed 2017-08-14 | $17.00K 10-Q · filed 2018-08-13 | $72.00K derived: sum of 3 quarters · filed 2018-08-13 | $72.00K derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | $7.00K 10-Q · filed 2018-08-13 | $48.00K 10-Q · filed 2017-05-09 | $65.00K derived: sum of 2 quarters · filed 2018-08-13 | $65.00K derived: sum of 3 quarters · filed 2018-08-13 | $65.00K derived: sum of 4 quarters · filed 2018-08-13 |
| 2016-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $58.00K derived: sum of 2 quarters · filed 2018-03-20 | $58.00K derived: sum of 3 quarters · filed 2018-03-20 | $58.00K 10-K · filed 2018-03-20 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | $0.00 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |